Vaxcyte
Zuqin X. is a Senior Scientist in Analytical Development at Vaxcyte, with prior experience as a Scientist II at Nektar Therapeutics and Senior Scientist II at Eurofins, all focusing on analytical methodologies. Zuqin began a career in academia with research and teaching assistant roles at the University at Buffalo and the University of South Carolina, specializing in chemistry and biochemistry. Academic qualifications include a PhD in Chemistry from the University at Buffalo and multiple master’s degrees in Biochemistry and Bioinorganic Chemistry from the University of South Carolina and Nanjing University, complemented by a BS in Chemistry from Nanjing University. Research efforts have included the design and synthesis of platinum-based anticancer compounds.
This person is not in any teams
This person is not in any offices
Vaxcyte
2 followers
Vaxcyte, formerly known as SutroVax, is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.